Markets › India › NSE › ASTRAZEN

AstraZeneca Pharma India Ltd

NSE:ASTRAZENHealthcare

₹6,039.50+1.16%At closeAt close · Mon 19 Oct · ≈ AED 233.02 · Market cap $1.57B

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	59.1%	55.6%	57.6%	48.0%	41.6%	26.5%	—	—
Operating margin	14.4%	8.6%	14.8%	13.2%	12.5%	10.3%	10.3%	+0.0 pts
Net margin	11.5%	7.6%	9.9%	12.5%	6.8%	8.2%	8.2%	+0.0 pts
EBITDA margin	18.3%	12.5%	15.1%	18.2%	11.5%	12.5%	—	—
Return on equity	20.5%	12.0%	16.9%	22.7%	15.0%	21.5%	21.5%	+0.0 pts
Return on assets	12.0%	7.2%	10.1%	15.0%	7.6%	9.4%	9.4%	+0.0 pts
Return on capital employed	24.7%	13.3%	24.8%	23.8%	26.4%	23.2%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.1×	0.1×	+0.0%
Debt / assets	1.6%	1.0%	0.7%	0.4%	2.4%	5.6%	—	—
Interest coverage	106.7×	73.3×	236.3×	142.9×	147.1×	52.0×	—	—
Current ratio	2.0×	2.1×	2.2×	2.6×	1.9×	1.8×	1.8×	+0.0%
Quick ratio	1.5×	1.7×	1.7×	2.0×	1.1×	0.7×	—	—
Cash ratio	1.2×	1.3×	1.3×	1.4×	0.8×	0.5×	0.5×	+0.0%
Asset turnover	1.0×	0.9×	1.0×	1.2×	1.1×	1.1×	—	—
Inventory turnover	2.1×	2.5×	2.2×	3.0×	1.8×	1.6×	—	—
Receivables turnover	9.5×	9.4×	8.5×	7.7×	9.3×	10.6×	—	—
Dividend payout	5.4%	8.1%	20.1%	24.8%	51.8%	42.7%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.